Farrukh N, Hageman L, Chen Y, et al. - Since older adults with hematologic malignancies are increasingly being offered blood or marrow transplantation (BMT), however, their risk of severe pain is poorly understood, researchers examined the prevalence and predictors of pain after BMT (allogeneic or autologous) and its correlation with physical performance impairments and frailty utilizing the Bone Marrow Transplant Survivor Study. The cohort involved 736 people with hematologic malignancies who had BMT at an age ≥ 60 years at 1 of 3 transplant centers between 1974 and 2014 and survived ≥ 2 years after BMT. In addition, 183 unaffected siblings engaged. According to findings, almost 40% of older BMT survivors who were followed for a median of 5 years after BMT reported pain, and BMT survivors had 2.6-fold higher chances of reporting severe, nonminor or life-interfering pain in comparison with siblings.